| Dr Samuel Suede, MD | |
|
25 Rockwood Pl, Suite 440, Englewood, NJ 07631-4957 | |
| (201) 568-3690 | |
| (201) 562-3667 |
| Full Name | Dr Samuel Suede |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 38 Years |
| Location | 25 Rockwood Pl, Englewood, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164503116 | NPI | - | NPPES |
| 5188407 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 25MA05797800 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Englewood Hospital And Medical Center | Englewood, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Associates Of Englewood Pc | 1355512252 | 519 |
News Archive
Results from a pre-specified interim analysis of a randomized, placebo-controlled Phase 3 study, COU-AA-301, demonstrate that patients treated with the investigational agent abiraterone acetate plus low-dose prednisone/prednisolone showed a significant improvement in overall survival compared to patients treated with prednisone/prednisolone plus placebo.
After a serious injury, the leading cause of death is loss of blood. Major trauma victims who receive transfusions of packed blood 22 days old or older may face increased risk of death within 24 hours, according to a new study in Annals of Emergency Medicine.
Celldex Therapeutics, Inc. today announced preliminary results from the Company's randomized Phase 2b EMERGE study of CDX-011 (glembatumumab vedotin) antibody drug conjugate in patients with glycoprotein NMB (GPNMB) expressing, advanced, heavily pretreated breast cancer. Preliminary results suggest that CDX-011 induces impressive response rates compared to current, available therapies in patients with advanced, refractory breast cancers with high GPNMB expression.
Vitamin D and calcium have been the focus of much research since the Institute of Medicine set nutritional reference values for them in 1997. Known as Dietary Reference Intakes, the values for these and other nutrients serve as a guide for good nutrition and provide the scientific basis for the development of food guidelines in both the United States and Canada. Updated DRIs for these two nutrients are presented in a new IOM report, Dietary Reference Intakes for Calcium and Vitamin D, which will be released on Tuesday, Nov. 30.
› Verified 5 days ago
| Entity Name | Medical Associates Of Englewood Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952681918 PECOS PAC ID: 1355512252 Enrollment ID: O20110927000020 |
News Archive
Results from a pre-specified interim analysis of a randomized, placebo-controlled Phase 3 study, COU-AA-301, demonstrate that patients treated with the investigational agent abiraterone acetate plus low-dose prednisone/prednisolone showed a significant improvement in overall survival compared to patients treated with prednisone/prednisolone plus placebo.
After a serious injury, the leading cause of death is loss of blood. Major trauma victims who receive transfusions of packed blood 22 days old or older may face increased risk of death within 24 hours, according to a new study in Annals of Emergency Medicine.
Celldex Therapeutics, Inc. today announced preliminary results from the Company's randomized Phase 2b EMERGE study of CDX-011 (glembatumumab vedotin) antibody drug conjugate in patients with glycoprotein NMB (GPNMB) expressing, advanced, heavily pretreated breast cancer. Preliminary results suggest that CDX-011 induces impressive response rates compared to current, available therapies in patients with advanced, refractory breast cancers with high GPNMB expression.
Vitamin D and calcium have been the focus of much research since the Institute of Medicine set nutritional reference values for them in 1997. Known as Dietary Reference Intakes, the values for these and other nutrients serve as a guide for good nutrition and provide the scientific basis for the development of food guidelines in both the United States and Canada. Updated DRIs for these two nutrients are presented in a new IOM report, Dietary Reference Intakes for Calcium and Vitamin D, which will be released on Tuesday, Nov. 30.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Samuel Suede, MD 25 Rockwood Pl, Suite 440, Englewood, NJ 07631-4957 Ph: (201) 568-3690 | Dr Samuel Suede, MD 25 Rockwood Pl, Suite 440, Englewood, NJ 07631-4957 Ph: (201) 568-3690 |
News Archive
Results from a pre-specified interim analysis of a randomized, placebo-controlled Phase 3 study, COU-AA-301, demonstrate that patients treated with the investigational agent abiraterone acetate plus low-dose prednisone/prednisolone showed a significant improvement in overall survival compared to patients treated with prednisone/prednisolone plus placebo.
After a serious injury, the leading cause of death is loss of blood. Major trauma victims who receive transfusions of packed blood 22 days old or older may face increased risk of death within 24 hours, according to a new study in Annals of Emergency Medicine.
Celldex Therapeutics, Inc. today announced preliminary results from the Company's randomized Phase 2b EMERGE study of CDX-011 (glembatumumab vedotin) antibody drug conjugate in patients with glycoprotein NMB (GPNMB) expressing, advanced, heavily pretreated breast cancer. Preliminary results suggest that CDX-011 induces impressive response rates compared to current, available therapies in patients with advanced, refractory breast cancers with high GPNMB expression.
Vitamin D and calcium have been the focus of much research since the Institute of Medicine set nutritional reference values for them in 1997. Known as Dietary Reference Intakes, the values for these and other nutrients serve as a guide for good nutrition and provide the scientific basis for the development of food guidelines in both the United States and Canada. Updated DRIs for these two nutrients are presented in a new IOM report, Dietary Reference Intakes for Calcium and Vitamin D, which will be released on Tuesday, Nov. 30.
› Verified 5 days ago
Dr. Annalisa Pastore, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 60 Grand Ave, Englewood, NJ 07631 Phone: 201-308-5326 | |
Deborah A Fein, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 177 N Dean St, Englewood, NJ 07631 Phone: 201-567-0446 | |
Jeffrey Martin Mitchel, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 370 Grand Ave, Englewood, NJ 07631 Phone: 201-567-7576 Fax: 201-567-8628 | |
Dennis Katechis, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 177 N Dean St, Suite 100, Englewood, NJ 07631 Phone: 201-816-2508 Fax: 201-569-6111 | |
Dr. Ebben Will Smith, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 370 Grand Ave, Suite 102, Englewood, NJ 07631 Phone: 201-567-3370 | |
Dr. Ma. Conchitina Manas Fojas, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 229 Engle St, Englewood, NJ 07631 Phone: 201-567-5385 | |
Steven J Weisholtz, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 25 Rockwood Pl, Englewood, NJ 07631 Phone: 201-568-8130 Fax: 201-568-2450 |